Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-005175
Filing Date
2025-11-14
Accepted
2025-11-14 18:41:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8866
  Complete submission text file 0001172661-25-005175.txt   10645
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 11 COMMERCE DRIVE FIRST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Subject) CIK: 0001851484 (see all company filings)

EIN.: 994362660 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93794 | Film No.: 251488774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)